Get started
3M DRN3M DRN3M DRN

3M DRN

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals Bonds

MMMC34 trade ideas

3M Company launches Solventum Corporation on NYSE. Idea 03/04/24The spin-off of 3M Company's healthcare division into a separate entity, Solventum Corporation, marks a significant strategic shift for the conglomerate. It allows 3M to focus on its core industrial and consumer businesses while giving Solventum the independence to thrive in the healthcare and hospitality sectors. Solventum's debut on the New York Stock Exchange under the ticker SOLV introduces a new player to the market, potentially offering fresh investment opportunities. The resolution of a legal dispute involving allegations of harmful chemical releases, with 3M Company successfully defending its practices and settling for 10 billion USD, underscores its resilience and ability to navigate complex regulatory and legal challenges. This development, combined with 3M's status as a dividend aristocrat – a testament to its long-standing commitment to shareholder returns – further solidifies its reputation in the investment community. Technical analysis of 3M Company (MMM) stock D1 timeframe analysis: 3M's stock has established a support level at 85.61 USD and a resistance level at 94.34 USD, indicating a strong uptrend with a sufficiently broad channel and a significant upside breakout potential. This pattern reflects investor confidence and a positive market response to the company's strategic decisions, including the recent spin-off and legal settlement. H1 timeframe analysis: for traders, the 94.34 USD resistance level breach presents an attractive entry point for long positions, with a short-term target set at 101.05 USD. Looking further ahead, maintaining a long position up to 108.37 USD could be advantageous in the medium term. This strategy capitalises on the momentum indicated by the daily timeframe analysis, with the potential for substantial gains as the market continues to digest 3M's recent developments and adjusts to Solventum Corporation's presence in the stock exchange. — Ideas and other content presented on this page should not be considered as guidance for trading or an investment advice. RoboMarkets bears no responsibility for trading results based on trading opinions described in these analytical reviews. The material presented and the information contained herein is for information purposes only and in no way should be considered as the provision of investment advice for the purposes of Investment Firms Law L. 87(I)/2017 of the Republic of Cyprus or any other form of personal advice or recommendation, which relates to certain types of transactions with certain types of financial instruments. Risk Warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 66.02% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
NYSE:MMM
by RoboMarkets
Analyzing 3M's PFAS Settlement: Impact on Stock PerformanceOn March 29, 3M ( NYSE:MMM ) announced that the settlement agreement with US public water suppliers (PWS) to address the presence of per- and polyfluoroalkyl substances (PFAS) in drinking water has received final approval from the US District Court in Charleston, South Carolina. The now-finalized agreement will offer support to PWS that detect PFAS at any level or may do so in the future, benefiting US-based PWS that provide drinking water to Americans across the country. The agreement was widely accepted and participated in by US PWS. As previously disclosed, 3M ( NYSE:MMM ) has recorded an accrual of $10.3 billion for this matter, which reflects the pre-tax present value of the expected payments over 13 years under the agreement. Payments under the agreement are scheduled to begin in the third quarter of 2024, provided there are no pending appeals of the final approval order. 3M ( NYSE:MMM ) also continues to actively engage in insurance recovery activities. In other news, Solventum celebrated its initial trading day as a publicly traded company on April 3. Solventum is a global healthcare leader with a diverse collection of strong, trusted, reputable brands and deep innovation capabilities; it is well positioned for success. It has a workforce of 22,000 employees led by CEO Bryan Hanson, CFO Wayde McMillan, and Board Chair Carrie Cox. Solventum offers solutions across four business segments – Medical Surgical, Dental Solutions, Health Information Systems, and Purification and Filtration. The company has a long heritage of creating innovative solutions that address its customers' most pressing issues related to patient care, efficient processes and workflow, and safety and accuracy standards. Solventum colleagues worldwide are united in their mission to enable better, smarter, safer healthcare to improve lives. For instance, Solventum products have been used in over two billion dental restoration procedures worldwide and are estimated to treat 1.6 million hard-to-heal wounds annually. Software solutions are used in many health systems worldwide, including over 75% of US hospitals, and membrane technology is currently utilized in more than 25 million life-saving dialysis treatments annually. By listening to healthcare providers and patients, Solventum will continue to seek new ways to achieve positive health outcomes and more efficient care. Solventum's CEO and members of the Solventum Leadership Team celebrated the company's first day as a publicly traded company by ringing the Opening Bell at the NYSE on April 3.
NYSE:MMMLong
by DEXWireNews
3M (MMM) 50% Drop Buying OpportunityFundamentals: New CEO William Brown Forward guidance for 2024 is positive. Sales are moving forward in a positive trajectory. It is not a super stock, but a cash flowed dividend payer. Possible recover in the balance sheet of 3M since 2021. Technicals: Quarterly 3M has falling 50% from 2021 highs and has reached a critical quarterly support area. Quarterly engulfing candle pattern at support, engulfing the prior two quarters. Quarterly extreme indicator Quarterly exDiv1 a-b-c equal legs completion Monthly: October 2023 hammer with ending volume (d1a) Multiple bullish candle patterns March 2024 engulfing candle pattern with higher volume All above events at quarterly support Weekly: MACD above zero with chikou above prices Daily: Daily stage 3 with shallow pb pattern
NYSE:MMMLong
by Rocketman
3M Shares Jump, As it Hires Outsider Bill Brown as CEOIndustrial conglomerate 3M ( NYSE:MMM ) has made a strategic move by appointing Bill Brown, former CEO of L3Harris Technologies, as its next chief executive officer. The decision comes amidst a challenging period for 3M ( NYSE:MMM ) , marked by declining sales and the looming repercussions of several lawsuits. With 3M's ( NYSE:MMM ) shares rallying nearly 7% following the announcement, the company is banking on Brown's expertise to navigate through turbulent waters and drive transformative change. Embracing Change Amidst Turmoil: 3M's decision to bring in an external CEO signals a clear desire for change amidst challenging financial and stock market performance. Analysts view this move as a positive step forward, particularly as the company grapples with the fallout from lawsuits related to its earplugs and environmental contaminants known as "forever chemicals." Brown's appointment represents a strategic pivot for 3M, leveraging his track record of driving margin improvement and implementing bold strategic initiatives. Navigating Industry Challenges: The industrial giant faces headwinds from a muted macroeconomic environment, particularly impacting its electronics business, which manufactures displays for smartphones and tablets. Slowing discretionary spending, particularly in China, has added to the company's woes. However, Brown's reputation for driving efficiency and executing strategic maneuvers positions 3M favorably to address these challenges head-on. Legal Settlements and Restructuring Efforts: 3M's ( NYSE:MMM ) recent legal settlements, including a $6.01 billion agreement to resolve claims related to Combat Arms earplugs and a tentative $10.3 billion settlement for water pollution claims, have put a strain on its financials. To mitigate the impact of slowing demand and legal liabilities, the company has embarked on a major restructuring initiative, involving job cuts and the spinoff of its healthcare business into a separate entity. These efforts underscore 3M's commitment to adapting to evolving market dynamics and restoring shareholder confidence. Conclusion: As 3M ( NYSE:MMM ) prepares for a leadership transition, stakeholders are cautiously optimistic about the company's future under Bill Brown's stewardship. With a proven track record in the aerospace and defense industry, Brown brings a wealth of experience and strategic vision to 3M. Despite the challenges ahead, including ongoing legal battles and market headwinds, 3M's appointment of an outsider as CEO signals a commitment to driving transformative change and positioning the company for long-term success in a rapidly evolving landscape.
NYSE:MMMLong
by DEXWireNews
3M (MMM) Navigates Challenges and Beats Earnings Estimates In a recent quarterly report, multinational conglomerate 3M ( NYSE:MMM ) showcased resilience in the face of challenges, beating earnings estimates for the fourth quarter of 2023. The maker of iconic products like Post-it notes and Scotch tape reported adjusted earnings of $2.42 per share, surpassing the Zacks Consensus Estimate of $2.31 per share. This marks a positive trend for the company, which has consistently outperformed earnings expectations over the last four quarters. Earnings Performance: 3M's earnings surprise of 4.76% in the latest quarter follows a robust performance a quarter ago, where the company exceeded expectations by a substantial 14.53%. Despite facing headwinds, 3M has demonstrated its ability to adapt and deliver strong financial results. The company's earnings growth from $2.28 per share a year ago to the current $2.42 per share reflects a steady upward trajectory. Revenue Resilience: While the quarterly revenues of $8.01 billion slightly fell short of the year-ago figure of $8.08 billion, 3M managed to beat the Zacks Consensus Estimate by an impressive 4.25%. This consistent ability to surpass revenue expectations highlights the company's agility in navigating market challenges. Guidance and Market Response: Despite the positive financial results, 3M's stock experienced an 11% drop to a seven-week low after the company provided its earnings guidance for 2024. The projected adjusted earnings of $9.35 to $9.75 per share fell below the consensus estimate of $9.82 per share. The market response underscores the significance investors place on forward-looking guidance. CEO Perspective and Strategic Initiatives: 3M's Chairman and CEO, Mike Roman, expressed optimism about the company's performance in 2023, citing successful execution of priorities, expansion of operating margins, and progress in organizational restructuring. The CEO emphasized initiatives such as simplifying the supply chain, advancing the healthcare spin-off, and addressing legal matters, including resolving litigation related to products like earplugs for soldiers and environmental concerns. Investor Concerns and the Path Forward: The discrepancy between the company's strong quarterly results and the cautious outlook for 2024 raises questions among investors. The potential impact of ongoing legal matters and the restructuring efforts initiated by 3M add an element of uncertainty. Investors are keenly awaiting insights from management during the upcoming earnings call, seeking clarity on the company's strategies to overcome challenges and capitalize on opportunities in the coming year. Conclusion: 3M's recent financial performance reflects a mix of resilience and caution, with the company navigating challenges successfully in the past year. As investors assess the stock's future potential, the focus shifts to management's commentary on the earnings call, where insights into the company's strategies, risk mitigation, and growth plans will play a crucial role in shaping investor sentiment. 3M's journey in 2024 will be closely watched, and the stock's trajectory may depend on how well the company addresses investor concerns and executes its strategic initiatives.
NYSE:MMM
by DEXWireNews
MMM … what is next MMM has been demonstrating robust financial performance, with earnings for the last two quarters coming in at $7.7 billion and $7.9 billion respectively. Currently, the stock is trading at the lower edge of its upper trend channel, indicating a potential buying opportunity for investors. Key levels to watch include $102, $105, and $112, which could serve as pivotal points for either a bounce back upwards or a breakdown. Wait for tomorrow FED talk tomorrow
NYSE:MMMLong
by DrSaud1
1
MMM long play3M had a decent earningsreport, however investors were not happy with the lack luster revnue forecast for 2024. Largest selloff since 2019. This opens up a great potential play. Short term fib retracement to .618, Has potential to keep moving to the downside. However some strong support at 93. And a bottom support of 85. Now for the upside potential. Looking at the current trend, it has a upper resistance from 160's for 2024 long term. Sizing in with potential stops at ~93
NYSE:MMMLong
by galactic_ventures
1
3M $MMM Trade IdeaI entered a trade on NYSE:MMM yesterday as the stock pulled back to the previous diagonal resistance after the previous day breakout. Today the price seems to be continuing its bullish movement after a simple S/R flip. The moving averages are all sloping up showing short term bullish momentum. We see that the oscillators are overbought in the short term so we might see a small pullback which I will use to add more options contracts to this position. Hope this helped the readers, follow me for more trade ideas. Thank you, BK
NYSE:MMMLong
by Konstandinovic
1